Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 166.67% vs -40.00% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 53.58% vs -202.45% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 19.35% vs -30.37% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 4.00% vs -16.67% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Humacyte, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 166.67% vs -40.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 53.58% vs -202.45% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 55.36% vs -50.77% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 19.35% vs -30.37% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 20.77% vs -21.89% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 4.00% vs -16.67% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 8.33% vs 60.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






